Household’s Catastrophic Health Expenditure in Patients With Type 2 Diabetes: A Study From Iran
Abstract
Introduction: Type 2 diabetes (T2D) is a chronic condition that substantially threatens public health due to its prevalence and severe adverse effects. Beyond its health consequences, T2D is associated with considerable financial burden. Accordingly, this study aimed to investigate the magnitude and determinants of catastrophic health expenditure (CHE) incurred by patients with T2D.
Methods: Overall, 400 participants with T2D participated in this cross-sectional study in 2022, and a researcher-made questionnaire was used for data collection. The allocation of at least 40% of non-food expenditures to healthcare (during the last year) was the basis for CHE calculation. The chi-square test was utilized to determine the statistical association between demographic and background variables and CHE occurrence.
Results: It was found that patients incur a mean annual cost of $1138, including 15.5%, 8.5%, and 76% spent on diagnostic expenses, medical visits, and treatment expenditures, respectively. Laboratory services, internist and endocrinologist visits, and medication accounted for the most considerable proportion of diagnostic, physician visits, and treatment costs. About 19.95% of direct medical costs were attributable to non-food costs, while 13.5% of patients experienced CHE. Educational status, employment status, indigenousness, residency in urban and rural areas, supplementary health insurance, disease treatment, the location of getting care, and the statistically significant link between the side effects and occurrence of CHE were among the demographic and
background variables.
Conclusion: Although the rate of CHE provided care to diabetic patients is reasonable, health policymakers still need to take steps to resolve the situation through promotion measures.
with delta variant of COVID-19: a cross-sectional study. Health Promot Perspect 2023;13(1):68-76. doi:10.34172/hpp.2023.09
2. Meshkat SAM, Kassaeian SS, Danaei N, Gharibi F. Households catastrophic health expenditure among older people with noncommunicable diseases: a cross-sectional study from Iran. Health Sci Rep 2024;7(3):e1992. doi:10.1002/hsr2.1992
3. Hsu J, Flores G, Evans D, Mills A, Hanson K. Measuring financial protection against catastrophic health expenditures:
methodological challenges for global monitoring. Int J Equity Health 2018;17(1):69. doi:10.1186/s12939-018-0749-5
4. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJ. Household catastrophic health expenditure: a multicountry analysis. Lancet 2003;362(9378):111-7. doi:10.1016/s0140-6736(03)13861-5
5. Piroozi B, Moradi G, Nouri B, Mohamadi Bolbanabad A, Safari H. Catastrophic health expenditure after the implementation of health sector evolution plan: a case study in the west of Iran. Int J Health Policy Manag 2016;5(7):417-23. doi:10.15171/ ijhpm.2016.31
6. Kavosi Z, Rashidian A, Pourreza A, Majdzadytuieh R, Pourmalek F, Hosseinpour AR, et al. Inequality in household
catastrophic health care expenditure in a low-income society of Iran. Health Policy Plan 2012;27(7):613-23. doi:10.1093/heapol/czs001
7. Yazdi-Feyzabadi V, Bahrampour M, Rashidian A, Haghdoost AA, Akbari Javar M, Mehrolhassani MH. Prevalence and
intensity of catastrophic health care expenditures in Iran from 2008 to 2015: a study on Iranian household income
and expenditure survey. Int J Equity Health 2018;17(1):44. doi:10.1186/s12939-018-0743-y
8. Xin XX, Zhao L, Guan XD, Shi LW. Determinants and equity evaluation for health expenditure among patients with rare
diseases in China. Chin Med J (Engl) 2016;129(12):1387-93. doi:10.4103/0366-6999.183425
9. Si Y, Zhou Z, Su M, Ma M, Xu Y, Heitner J. Catastrophic healthcare expenditure and its inequality for households
with hypertension: evidence from the rural areas of Shaanxi province in China. Int J Equity Health 2017;16(1):27. doi:10.1186/s12939-016-0506-6
10. Forouzanfar MH, Ghajarieh Sepanlou S, Shahraz S, Dicker D, Naghavi P, Pourmalek F, et al. Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med 2014;17(5):304-20.
11. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin
Pract 2010;87(1):4-14. doi:10.1016/j.diabres.2009.10.007
12. Beiranvand S, Fayazi S, Asadizaker M, Latifi SM. Survey of the foot care status in type II diabetic patients: application of the theory of planned behavior. J Clin Nurs Midwifery 2014;3(2):57-66.
13. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence
of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract 2014;103(2):319-27. doi:10.1016/j.diabres.2013.12.034
14. Ahmed SA, Badi S, Tahir H, Ahmed MH, Almobarak AO. Knowledge and practice of diabetic foot care in Sudan: a cross sectional survey. Diabetes Metab Syndr 2019;13(4):2431-5. doi:10.1016/j.dsx.2019.06.016
15. Venkataraman K, Kannan AT, Mohan V. Challenges in diabetes management with particular reference to India. Int J Diabetes Dev Ctries 2009;29(3):103-9. doi:10.4103/0973-3930.54286
16. Ohinmaa A, Jacobs P, Simpson S, Johnson JA. The projection of prevalence and cost of diabetes in Canada: 2000 to 2016. Can J Diabetes 2004;28(2):116-23.
17. Ghorbanian A, Rashidian A, Bagheri Lankarani K, Kavosi Z. The prevalence and determinants of catastrophic
health expenditures in Iran: a systematic review and metaanalysis. Health Scope 2017:8(1):e63210. doi:10.5812/ jhealthscope.63210
18. Lu C, Chin B, Li G, Murray CJ. Limitations of methods for measuring out-of-pocket and catastrophic private health
expenditures. Bull World Health Organ 2009;87(3):238-44. doi:10.2471/BLT.08.054379
19. Wang Z, Li X, Chen M. Catastrophic health expenditures and its inequality in elderly households with chronic disease
patients in China. Int J Equity Health 2015;14:8. doi:10.1186/s12939-015-0134-6
20. Mutyambizi C, Pavlova M, Hongoro C, Booysen F, Groot W. Incidence, socio-economic inequalities and determinants
of catastrophic health expenditure and impoverishment for diabetes care in South Africa: a study at two public hospitals
in Tshwane. Int J Equity Health 2019;18(1):73. doi:10.1186/s12939-019-0977-3
21. Nekoei Moghadam M, Banshi M, Akbari Javar M, Amiresmaili M, Ganjavi S. Iranian household financial protection against catastrophic health care expenditures. Iran J Public Health 2012;41(9):62-70.
22. Jing Z, Chu J, Imam Syeda Z, Zhang X, Xu Q, Sun L, et al. Catastrophic health expenditure among type 2 diabetes
mellitus patients: a province-wide study in Shandong, China. J Diabetes Investig 2019;10(2):283-9. doi:10.1111/jdi.12901
23. Sun X, Liabsuetrakul T, Xie X, Liu P. Catastrophic health expenditure and impoverishment for type 2 diabetes
mellitus patients in a multiethnic province in China using a Blinder-Oaxaca decomposition: a cross-sectional study.
Medicine (Baltimore) 2019;98(39):e17376. doi:10.1097/md.0000000000017376
| Files | ||
| Issue | Vol 10 No 2 (2026) | |
| Section | Articles | |
| Keywords | ||
| Direct medical costs; Catastrophic health expenditure; Type 2 diabetes | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
